Gamma Biologicals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gamma Biologicals

GBL 24.34

-2.6%

Oct 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: A. Reader who wrote (24)	11/14/1997 8:06:00 AM
From: A. Reader	Read Replies (1) of 44

Gamma Biologicals Reports Earnings For Second Quarter and Six Months Ended September 30, 1997 Gamma-ReACT, Now FDA Approved to Market, Generates Interest at AABB... ...''We received FDA acceptance just prior to the American Association of Blood Banks (AABB) annual meeting, a marketing 'plus' for Gamma,'' Hatcher reported. ''ReACT's ease of use, marked by our ready-to-use cell suspension, generated considerable interest at the AABB. Our domestic sales force is looking forward to translating that interest into sales. We have already shipped or have orders for more than 40 systems for the international markets. ''Preliminary marketing data indicate that the ReACT system could contribute $3 million to revenues during the first full year of sales,'' said Hatcher. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next